Loading...
XETR
M12
Market cap309mUSD
Jun 26, Last price  
14.32EUR
1D
-3.13%
1Q
-2.99%
Jan 2017
35.23%
IPO
174.23%
Name

M1 Kliniken AG

Chart & Performance

D1W1MN
P/E
25.86
P/S
0.84
EPS
0.55
Div Yield, %
3.51%
Shrs. gr., 5y
2.61%
Rev. gr., 5y
37.14%
Revenues
316m
+10.88%
6,081,00023,017,00034,926,33435,955,00047,194,52565,208,58677,216,857159,590,839314,610,275285,291,186316,318,613
Net income
10m
+137.98%
109,0004,585,0006,630,7555,007,4605,777,9716,612,5679,729,0306,823,0108,905,0914,317,35410,274,283
CFO
9m
-57.58%
-5,215,000912,575-171,7967,936,0002,085,9642,860,919-3,524,3119,381,13415,658,05521,023,1318,917,096
Dividend
Jul 18, 20240.5 EUR/sh
Earnings
Sep 01, 2025

Profile

M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
URL
https://www.m1-kliniken.de/
IPO date
Sep 14, 2015
Employees
366
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
316,319
10.88%
285,291
-9.32%
Cost of revenue
290,894
272,554
Unusual Expense (Income)
NOPBT
25,424
12,737
NOPBT Margin
8.04%
4.46%
Operating Taxes
4,779
3,163
Tax Rate
18.80%
24.83%
NOPAT
20,645
9,574
Net income
10,274
137.98%
4,317
-51.52%
Dividends
(1,981)
(1,823)
Dividend yield
0.92%
1.10%
Proceeds from repurchase of equity
3,949
13,804
BB yield
-1.84%
-8.32%
Debt
Debt current
2,971
6,219
Long-term debt
20,493
13,449
Deferred revenue
10,324
Other long-term liabilities
11
54
Net debt
(231)
(39,834)
Cash flow
Cash from operating activities
8,917
21,023
CAPEX
(455)
(1,772)
Cash from investing activities
(9,364)
(1,770)
Cash from financing activities
(14,809)
(21,968)
FCF
14,149
15,192
Balance
Cash
22,756
47,499
Long term investments
939
12,003
Excess cash
7,879
45,237
Stockholders' equity
99,734
107,095
Invested Capital
148,025
114,863
ROIC
15.71%
8.03%
ROCE
16.12%
7.81%
EV
Common stock shares outstanding
19,126
18,315
Price
11.20
23.62%
9.06
20.80%
Market cap
214,210
29.09%
165,934
19.08%
EV
243,953
175,532
EBITDA
30,735
18,600
EV/EBITDA
7.94
9.44
Interest
1,347
828
Interest/NOPBT
5.30%
6.50%